Back to TVTX
D. E. Shaw & Co., Inc. TVTX Position History
Travere Therapeutics, Inc. • Healthcare
Quarters held
28
Latest value
$19.4M
Q2 2026
Peak value
$62.4M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $8.2M |
| Q2 2022 | $2.2M |
| Q3 2022 | $6.8M |
| Q3 2022 | $2.5M |
| Q4 2022 | $7.3M |
| Q4 2022 | $2.5M |
| Q4 2023 | $10M |
| Q4 2023 | $4.9M |
| Q1 2024 | $9.6M |
| Q1 2024 | $4.6M |
| Q2 2024 | $8.2M |
| Q2 2024 | $4.4M |
| Q3 2024 | $19M |
| Q3 2024 | $6.8M |
| Q4 2024 | $31.4M |
| Q4 2024 | $8.3M |
| Q1 2025 | $21.8M |
| Q1 2025 | $8.9M |
| Q2 2025 | $8.5M |
| Q2 2025 | $8.2M |
| Q3 2025 | $5.9M |
| Q3 2025 | $10M |
| Q4 2025 | $28.7M |
| Q4 2025 | $13.2M |
| Q1 2026 | $12.6M |
| Q1 2026 | $12.3M |
| Q2 2026 | $62.4M |
| Q2 2026 | $19.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $19.4M | 341.6K | — | — |
| Q2 2026 | $62.4M | 1.10M | — | — |
| Q1 2026 | $12.3M | 413.8K | — | — |
| Q1 2026 | $12.6M | 422.8K | — | — |
| Q4 2025 | $13.2M | 344.3K | — | — |
| Q4 2025 | $28.7M | 750.2K | — | — |
| Q3 2025 | $10M | 418.0K | — | — |
| Q3 2025 | $5.9M | 245.3K | — | — |
| Q2 2025 | $8.2M | 555.1K | — | — |
| Q2 2025 | $8.5M | 575.7K | — | — |
| Q1 2025 | $8.9M | 495.6K | — | — |
| Q1 2025 | $21.8M | 1.22M | — | — |
| Q4 2024 | $8.3M | 477.7K | — | — |
| Q4 2024 | $31.4M | 1.80M | — | — |
| Q3 2024 | $6.8M | 484.7K | — | — |
| Q3 2024 | $19M | 1.36M | — | — |
| Q2 2024 | $4.4M | 529.8K | — | — |
| Q2 2024 | $8.2M | 1.00M | — | — |
| Q1 2024 | $4.6M | 595.1K | — | — |
| Q1 2024 | $9.6M | 1.25M | — | — |
| Q4 2023 | $4.9M | 546.7K | — | — |
| Q4 2023 | $10M | 1.11M | — | — |
| Q4 2022 | $2.5M | 119.5K | — | — |
| Q4 2022 | $7.3M | 347.4K | — | — |
| Q3 2022 | $2.5M | 101.2K | — | — |
| Q3 2022 | $6.8M | 274.6K | — | — |
| Q2 2022 | $2.2M | 90.4K | — | — |
| Q2 2022 | $8.2M | 338.4K | — | — |
Other funds holding TVTX
$241.8M
$241.8M
$218.9M
$147.4M
$104.1M